Key Ingredients

• Fexofenadine (120mg): Fexofenadine is a non-sedating antihistamine, mainly effective in treating solar urticaria (skin reactions caused by sunlight). While studies show it is not very effective for motion sickness, it excels in reducing symptoms of seasonal and perennial allergic rhinitis by blocking histamine action, thereby relieving sneezing, runny nose, and itchy eyes.​

• Acebrophylline (SR) 200mg: Acebrophylline is renowned for its anti-inflammatory and bronchodilatory properties. It acts as both a prophylactic and therapeutic agent in chronic asthma—expanding bronchial passages, reducing mucus, and relieving airway inflammation. Its safety and efficacy profile make it a preferred choice for long-term management of chronic respiratory diseases, offering relief from cough and breathing difficulties linked to airway constriction.​

• Montelukast Sodium (10mg): Montelukast blocks leukotriene receptors, reducing inflammation and allergic reactions in the airways. It is a potent airway mucus regulator, helping to prevent asthma attacks and reduce symptoms of allergic rhinitis by minimizing mucosal swelling and airway inflammation. Montelukast’s anti-inflammatory action further protects against triggers that lead to chronic asthma and respiratory distress.​

Therapeutic Benefits

• Comprehensive Allergy & Asthma Control: The combination of an antihistamine, bronchodilator, and leukotriene antagonist provides broad coverage against symptoms of allergic rhinitis, chronic asthma, and urticaria, ensuring rapid and sustained symptom relief.

• Respiratory Symptom Management: Acebrophylline’s dual-action—reducing airway inflammation and relaxing bronchial muscles—supports effective management of COPD and chronic asthma, promoting easier breathing and improved lung function.

• Anti-Allergic & Anti-Inflammatory: Montelukast and Fexofenadine together mitigate allergic reactions and mucus overproduction, decreasing the frequency and severity of respiratory symptoms.

• Safe for Long-Term Use: Each constituent is selected for its safety profile, making Fixolin-M suitable for chronic administration in respiratory and allergic disorders.​

Indications

Fixolin-M is recommended for patients suffering from:

• Chronic asthma

• Seasonal allergic rhinitis

• Perennial allergic rhinitis

• Urticaria (skin allergy)

• It is also beneficial in managing chronic respiratory symptoms associated with COPD.​

Application

Taken as directed by healthcare professionals, Fixolin-M helps patients achieve better control of respiratory allergies and chronic asthma, allowing freedom from frequent symptoms and improved quality of life.

Summary

Fixolin-M represents an advanced therapy for asthma, COPD, and allergic rhinitis, offering triple-layered protection against allergy, inflammation, and airway spasm. The synergy of Fexofenadine, Acebrophylline, and Montelukast Sodium empowers patients to enjoy relief from chronic respiratory and allergic symptoms, ensuring optimal airway health year-round.